Analysis on cost-benefit for infant hepatitis B vaccine immunization strategy in Beijing

  Objective   To demonstrate economic benefit of the current strategy for infancy hepatitis B vaccine immunization with the credible data from the disease surveillance of Beijing Disease Control Center.

  Methods   To adopt both methods of multistage sampling and random sampling in the communities and the hospital of Beijing areas respectively.The evaluation for the infant hepatitis B immunization strategy used in Beijing since 1990's was conducted with analysis models of costbenefit.

  Results   85.83 million Yuan net benefit would be obtained compared with the cost of 6.96 million Yuan for the vaccination.The BCR was 13.33.

  Conclusion   The current immunization strategy of infant hepatitis B vaccination in Beijing would acquire huge economic benefit and it should be consolidated.